USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/23608
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDavid, Valeriu-
dc.contributor.authorPetrovici, Vergil-
dc.contributor.authorSaptefrati, Lilian-
dc.contributor.authorFulga, Veaceslav-
dc.contributor.authorCarpenco, Ecaterina-
dc.contributor.authorFrant, Elena-
dc.date.accessioned2023-01-28T12:16:40Z-
dc.date.available2023-01-28T12:16:40Z-
dc.date.issued2022-
dc.identifier.citationDAVID, Valeriu, PETROVICI, Vergil, SAPTEFRATI, Lilian, et al. Evaluation of p57 expression in early disordered pregnancies with molar status vs non-molar ones. In: The Moldovan Medical Journal. 2022, vol. 65, no 2, pp. 33-36. ISSN 2537-6381. https://doi.org/10.52418/moldovan-med-j.65-2.22.01en_US
dc.identifier.issn2537-6373-
dc.identifier.issn2537-6381-
dc.identifier.urihttps://moldmedjournal.md/wp-content/uploads/2022/12/02-Moldovan-Med-J-2022-Vol65-No2.pdf-
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/23608-
dc.description.abstractBackground: The molar and non-molar lesions are determined during histomorphological examination and treated as inconclusive. The establishing of a marker by immunohistochemical investigations could influence the accuracy of the morphopathological diagnosis. The aim is evaluation of p57 immunoexpression in the trophoblastic germ compartment in molar and non-molar pregnancies. Material and methods: Abortion products from 15 patients with hydatidiform mole, 18 pregnancies solved on social indications and 16 short-term disordered pregnancies were evaluated depending on the immunoexpresion of p57. Results: The hydatidiform mole was classified based on anti-p57 immunoexpression into: complete hydatidiform mole – 8 cases (negative immunoexpression or expression in ˂10% of villous cytotrophoblast) and partial hydatidiform mole – 7 cases (positive expression in ˃10% of the villous cytotrophoblast). Basal deciduous and extravillous cytotrophoblasts were positive in 100% of cases and served as internal control. Hepatocytes were used as negative control. In the control group, the positive immunoexpression was attested in >10% of cases in the villous trophoblast. Conclusions: Differential immunoexpression of p57 protein in the germinal cytotrophoblast allows subclassification of molar pathology into complete and partial forms, while not allowing the differentiation between partial hydatidiform mole and non-molar lesions. Immunohistochemical evaluation of p57kip2 protein in molar and non-molar pathology is useful in differential diagnosis as a complementary method.en_US
dc.language.isoenen_US
dc.publisherThe Scientific Medical Association of the Republic of Moldovaen_US
dc.relation.ispartofThe Moldovan Medical Journalen_US
dc.subjectanti-p57en_US
dc.subjectfetal concepten_US
dc.subjecthydatidiform moleen_US
dc.subjecttrophoblastic diseaseen_US
dc.subject.ddcUDC: 618.32+611.013en_US
dc.titleEvaluation of p57 expression in early disordered pregnancies with molar status vs non-molar onesen_US
dc.typeArticleen_US
Appears in Collections:The Moldovan Medical Journal. Vol. 65, No 2, December 2022

Files in This Item:
File Description SizeFormat 
Evaluation_of_p57_expression_in_early_disordered_pregnancies.pdf3.15 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback